5:43 PM
 | 
Apr 29, 2014
 |  BC Extra  |  Financial News

GlobeImmune sets IPO range

GlobeImmune Inc. (Louisville, Colo.) amended its IPO on NASDAQ and now plans to sell 2.2 million shares at $15-$17. At the $16 midpoint, the company would raise $35 million and be valued at $92.2 million. Aegis Capital is underwriter. GlobeImmune...

Read the full 182 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >